ATP6V1H Deficiency Impairs Bone Development through Activation of MMP9 and MMP13

The National Institutes of Health undiagnosed diseases program

(2014) Cynthia J. Tifft et al.   CURRENT OPINION IN PEDIATRICS

Activation of Matrix Metalloproteinases 2, 9, and 13 by Activated Protein C in Human Osteoarthritic Cartilage Chondrocytes

(2014) Miriam T. Jackson et al.   Arthritis & Rheumatology

The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases

(2012) William A. Gahl et al.   GENETICS IN MEDICINE

V-ATPases in osteoclasts: Structure, function and potential inhibitors of bone resorption

(2012) A. Qin et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Small-Molecule Anticancer Compounds Selectively Target the Hemopexin Domain of Matrix Metalloproteinase-9

(2011) A. Dufour et al.   CANCER RESEARCH

The NIH Undiagnosed Diseases Program

(2011) William A. Gahl   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The a3 Isoform Vacuolar Type H+-ATPase Promotes Distant Metastasis in the Mouse B16 Melanoma Cells

(2011) T. Nishisho et al.   MOLECULAR CANCER RESEARCH

Matrix metalloproteinases in osteoclasts of ontogenetic and regenerating zebrafish scales

(2010) Erik de Vrieze et al.   BONE

Matrix Metalloproteinase (MMP)-13 Regulates Mammary Tumor–Induced Osteolysis by Activating MMP9 and Transforming Growth Factor-β Signaling at the Tumor-Bone Interface

(2010) Kalyan C. Nannuru et al.   CANCER RESEARCH

Circulating matrix metalloproteinase-9 and osteoporosis in patients with chronic obstructive pulmonary disease

(2009) CE Bolton et al.   Chronic Respiratory Disease